Literature DB >> 8769690

Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant Registry.

M M Horowitz1, P A Rowlings, J R Passweg.   

Abstract

The International Bone Marrow Transplant Registry (IBMTR), established in 1972, collects data on recipients of allogeneic bone marrow transplants from over 320 institutions, worldwide. Its database includes information for about 40% of all allogeneic transplants performed between 1964 and 1995.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8769690

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  13 in total

1.  Beyond bone marrow: a new source of stem cells.

Authors:  C I Chen; A Keating
Journal:  CMAJ       Date:  2001-03-06       Impact factor: 8.262

2.  Effective use of imatinib-mesylate in the treatment of relapsed chronic myeloid leukemia after allogeneic transplantation.

Authors:  Amjad Hayat; Shaun R McCann; Stephen Langabeer; Sandra Irvine; Mary Frances McMullin; Eibhlin Conneally
Journal:  Haematologica       Date:  2008-12-23       Impact factor: 9.941

3.  Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia.

Authors:  Bipin N Savani; Katayoun Rezvani; Stephan Mielke; Aldemar Montero; Roger Kurlander; Charles S Carter; Susan Leitman; Elizabeth J Read; Richard Childs; A John Barrett
Journal:  Blood       Date:  2005-08-30       Impact factor: 22.113

4.  Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy.

Authors:  Jaspal Kaeda; Derville O'Shea; Richard M Szydlo; Eduardo Olavarria; Francesco Dazzi; David Marin; Susan Saunders; Jamshid S Khorashad; Nicholas C P Cross; John M Goldman; Jane F Apperley
Journal:  Blood       Date:  2006-01-31       Impact factor: 22.113

5.  NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia.

Authors:  Susan O'Brien; Ellin Berman; Joseph O Moore; Javier Pinilla-Ibarz; Jerald P Radich; Paul J Shami; B Douglas Smith; David S Snyder; Hema M Sundar; Moshe Talpaz; Meir Wetzler
Journal:  J Natl Compr Canc Netw       Date:  2011-02       Impact factor: 11.908

6.  Comparison of myeloablative and nonmyeloablative hematopoietic stem cell transplantation for treatment of chronic myeloid leukemia.

Authors:  Ming-Huang Chen; Tzeon-Jye Chiou; Peng-Chan Lin; Jyh-Pyng Gau; Hui-Chi Hsu; Liang-Tsai Hsiao; Jin-Hwang Liu; Po-Min Chen
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

Review 7.  Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts.

Authors:  Christian Sillaber; Matthias Mayerhofer; Hermine Agis; Verena Sagaster; Christine Mannhalter; Wolfgang R Sperr; Klaus Geissler; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

8.  Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan.

Authors:  Masahiro Imamura; Shigetaka Asano; Mine Harada; Yasuo Ikeda; Koji Kato; Shunichi Kato; Keisei Kawa; Seiji Kojima; Yasuo Morishima; Yoshihisa Morishita; Tatsutoshi Nakahata; Jun Okamura; Shinichiro Okamoto; Shintaro Shiobara; Mitsune Tanimoto; Masahiro Tsuchida; Yoshiko Atsuta; Kazuhito Yamamoto; Junji Tanaka; Nobuyuki Hamajima; Yoshihisa Kodera
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

9.  Efficacy and safety profile of generic imatinib in patients with newly diagnosed chronic myeloid leukemia-chronic phase: sharing experience of a hemato-oncology center from eastern India.

Authors:  Abhijit Phukan; Prakas Kumar Mandal; Tuphan K Dolai
Journal:  Ann Hematol       Date:  2020-10-06       Impact factor: 3.673

Review 10.  Best Practices in Chronic Myeloid Leukemia Monitoring and Management.

Authors:  Simona Soverini; Caterina De Benedittis; Manuela Mancini; Giovanni Martinelli
Journal:  Oncologist       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.